Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study

Commentary: Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study

Bibliographic Details
Main Authors:	Hui Liu, Hongling Yu, Ting Li, Yerong Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Pharmacology
Subjects:	euglycemic clamp pharmacokinetics pharmacodynamics C-peptide insulin preparations
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.843658/full

Similar Items

How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers
by: Hui Liu, et al.
Published: (2022-07-01)

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
by: Yi Tao, et al.
Published: (2021-12-01)

Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
by: Alexander Y. Mayorov, et al.
Published: (2018-12-01)

Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects
by: Shin D, et al.
Published: (2019-04-01)

Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
by: Hanne Haahr, et al.
Published: (2020-06-01)

Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus® in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints
by: Yiya Wang, et al.
Published: (2022-08-01)

Investigation of d-allulose effects on high-sucrose diet-induced insulin resistance via hyperinsulinemic-euglycemic clamps in rats
by: Yukie Natsume, et al.
Published: (2021-09-01)

Pharmacokinetics, pharmacodynamics, and safety of prandial oral insulin (N11005) in healthy subjects
by: Qi Pan, et al.
Published: (2023-07-01)

Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection
by: Jiangjie Lu, et al.
Published: (2020-11-01)

The application of 2-NBDG as a fluorescent tracer for assessing hepatic glucose production in mice during hyperinsulinemic euglycemic clamp
by: Shuainan Liu, et al.
Published: (2012-08-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

High-dose Insulin Euglycemic Therapy
by: Jasmin Hamzić
Published: (2022-01-01)

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300
by: Oppel B.W. Greeff, et al.
Published: (2018-08-01)

When MINMOD Artifactually Interprets Strong Insulin Secretion as Weak Insulin Action
by: Joon Ha, et al.
Published: (2021-04-01)

Special aspects of concentrated insulins: basic characteristics and research findings
by: Tatiana Y. Demidova, et al.
Published: (2019-12-01)

Insulin Resistance in Children
by: Veronica Maria Tagi, et al.
Published: (2019-06-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-12-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Pharmacodynamics and pharmacokinetics of nalbuphine in xylazine‑sedated horses
by: Amal Hammad, et al.
Published: (2023-05-01)

Assessment of insulin sensitivity/resistance
by: Manish Gutch, et al.
Published: (2015-01-01)

Methods for guantificative assessment of insulin resistance
Published: (2009-06-01)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Acute effects of euglycemic‐hyperinsulinemia on myocardial contractility in male mice
by: Satya Murthy Tadinada, et al.
Published: (2022-09-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
by: Roganović Maša, et al.
Published: (2021-01-01)

Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes
by: Motonori Sato, et al.
Published: (2021-09-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Methods for assessing insulin resistance in gestational diabetes mellitus
by: N. I. Volkova, et al.
Published: (2022-03-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Childhood-Onset GH Deficiency versus Adult-Onset GH Deficiency: Relevant Differences Regarding Insulin Sensitivity
by: Heraldo Mendes Garmes, et al.
Published: (2022-12-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Pharmacodynamics and pharmacokinetics interaction between nefopam and tramadol in the broiler chicks model
by: Yaareb J. Mousa, et al.
Published: (2022-04-01)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
by: Hwang I, et al.
Published: (2020-10-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
by: Yaxin Fan, et al.
Published: (2022-06-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)